Bezeq the Israel Telecommunication Corp. Ltd. achieves unprecedented ruling before the Supreme Court

Gornitzky’s Dispute Resolution team successfully represented Bezeq the Israel Telecommunication Corp. Ltd. before the Israeli Supreme Court, resulting in an exceptional ruling in favour of Bezeq, dismissing two appeals over the decision of the honourable Judge Kaboub at the Tel Aviv District Court which denied two motions to approve a derivative suit. Among others, the […]

RedHill Biopharma’s $39 Million Underwritten Public Offering

Gornitzky represented the underwriters, led by Roth Capital Partners, in RedHill Biopharma’s USD 39 million underwritten public offering of American Depositary Shares (ADSs) and warrants on the NASDAQ Capital Market and concurrent registered direct offering of its ADSs and warrants. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases […]

Rafael Development Corporation Ltd’s investment in Cyber Secdo Ltd

Raved, Magriso, Benkel & Co. represented RDC – Rafael Development Corporation Ltd in its investment in Cyber Secdo Ltd, a company engaged in the Cyber Security (security threats within an organization’s network), as part of an equity financing round of the company. RDC -Rafael Development Corporation Ltd. develops and commercializes technologies for high-growth civilian markets […]

Careem Inc.’s $ 350 million Series E fundraising

Conyers Dill & Pearman acted as British Virgin Islands legal counsel to BVI-incorporated Dubai-based ride-sharing platform Careem Inc. on its successful US$ 350 million Series E fundraising from Rakuten, Inc. of Japan, Saudi Telecom Company and other private equity and venture capital investors. Careem Networks FZ LLC provides private car booking services. The company enables […]

Protalix BioTherapeutics, Inc.’s $54.1 Million private notes exchange agreement, and a $22.5 Million private placement of the company’s Secured Convertible Notes

Horn & Co. acted as Israeli counsel to Protalix BioTherapeutics, Inc. (NYSE: PLX) in a $54.1 Million private notes exchange agreement, and a $22.5 Million private placement of the company’s Secured Convertible Notes Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX) (the “Company”) announced today the entry into a definitive exchange agreement relating to an exchange (the […]

Yves Rocher Group’s acquisition of a majority stake in Sabon Shel Pa’am

Gornitzky represented Sabon Shel Pa’am (“Sabon”) and its Shareholders in the sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group. Sabon is a leading producer and retailer of cosmetic, body care, home style and ambience products sold in concept stores around the world. Yves Rocher is a worldwide […]